The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine

Richtand, N.M.; Logue, A.D.; Welge, J.A.; Perdiue, J.; Tubbs, L.J.; Spitzer, R.H.; Sethuraman, G.; Geracioti, T.D.

Brain Research 867(1-2): 239-242

2000


ISSN/ISBN: 0006-8993
PMID: 10837819
DOI: 10.1016/s0006-8993(00)02247-2
Accession: 011490308

Download citation:  
Text
  |  
BibTeX
  |  
RIS

Article/Abstract emailed within 0-6 h
Payments are secure & encrypted
Powered by Stripe
Powered by PayPal

Abstract
Behavioral sensitization is a well-studied model of behavioral plasticity mediated at least in part by dopaminergic systems believed to play an important role in several psychiatric conditions. In the rodent, locomotion is regulated by the opposing balance of D3 and D2 receptors, with D2 activation increasing and D3 stimulation inhibiting locomotion. However, receptor occupancy of D3 dopamine receptors is far greater than D2 or D1 occupancy at typical post-stimulant dopamine concentrations. We therefore hypothesized that tolerance of D3 receptor inhibition of locomotion contributes to the development of sensitization. To test this hypothesis, we examined the effect of the D3 receptor antagonist nafadotride on sensitization. As predicted, nafadotride inhibits augmentation of the locomotion response to repetitive amphetamine. This finding is consistent with the proposed model of adaptive down-regulation of D3 dopamine receptor function contributing to the development of behavioral sensitization.